Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model
Hyeon Jeong Kim, Bo Ko Jang, Jong‐Hyun Park, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111777-111777
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Chalcones: Synthetic Chemistry Follows Where Nature Leads
Hiba A. Jasim, Lutfun Nahar, Mohammed Jasim, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1203-1203
Open Access | Times Cited: 97
Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain
Jian Li, Mou‐Li Tian, Hua Tong, et al.
Autophagy (2021) Vol. 17, Iss. 12, pp. 4062-4082
Open Access | Times Cited: 80
Attenuation of Nrf2/Keap1/ARE in Alzheimer’s Disease by Plant Secondary Metabolites: A Mechanistic Review
Sajad Fakhri, Mirko Pesce, Antonia Patruno, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 4926-4926
Open Access | Times Cited: 74
Levistilide A ameliorates neuroinflammation via inhibiting JAK2/STAT3 signaling for neuroprotection and cognitive improvement in scopolamine-induced Alzheimer’s disease mouse model
H. Ni, Yanfang Liao, Yifan Zhang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110783-110783
Closed Access | Times Cited: 26
Activators of Nrf2 to Counteract Neurodegenerative Diseases
Rosa Amoroso, Cristina Maccallini, Ilaria Bellezza
Antioxidants (2023) Vol. 12, Iss. 3, pp. 778-778
Open Access | Times Cited: 24
Activation of Nrf2 signaling pathway by natural and synthetic chalcones: a therapeutic road map for oxidative stress
Melford C. Egbujor, Sarmistha Saha, Brigitta Buttari, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 4, pp. 465-480
Open Access | Times Cited: 43
Nrf2 pathways in neuroprotection: Alleviating mitochondrial dysfunction and cognitive impairment in aging
Asif Ahmad Bhat, Ehssan Moglad, Ahsas Goyal, et al.
Life Sciences (2024) Vol. 357, pp. 123056-123056
Closed Access | Times Cited: 6
Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents
Min Wang, Tongtong Liu, Shi-Ming Chen, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112874-112874
Closed Access | Times Cited: 49
Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19
Ranjana Bhandari, Garima Khanna, Dhriti Kaushik, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 7, pp. 3347-3361
Open Access | Times Cited: 34
Design, Synthesis, and Activity Evaluation of Fluorine-Containing Scopolamine Analogues as Potential Antidepressants
Le Wang, Xushuo Zhu, Bo Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5391-5420
Closed Access | Times Cited: 4
Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Antioxidants in Anti-Alzheimer's Disease Drug Discovery
Jianan Guo, Yalan Zhu, Jia Zhi, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102707-102707
Closed Access
Phloroglucinol Derivatives Exert Anti‐Inflammatory Effects and Attenuate Cognitive Impairment in LPS‐Induced Mouse Model
Jushin Kim, Ji Won Choi, Hyeon Jeong Kim, et al.
ChemMedChem (2024) Vol. 19, Iss. 17
Open Access | Times Cited: 3
Novel anti-inflammatory agents featuring phenoxy acetic acid moiety as a pharmacophore for selective COX-2 inhibitors: Synthesis, biological evaluation, histopathological examination and molecular modeling investigation
Mohamed K. Elgohary, Mahmoud F. Abo-Ashour, Soha R. Abd El Hadi, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107727-107727
Closed Access | Times Cited: 3
Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson’s disease
Jin‐Sung Choi, Siwon Kim, Jong Seok Yoo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 212, pp. 113103-113103
Closed Access | Times Cited: 27
Identification and optimization of piperlongumine analogues as potential antioxidant and anti-inflammatory agents via activation of Nrf2
Limei Ji, Lailiang Qu, Cheng Wang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 210, pp. 112965-112965
Closed Access | Times Cited: 25
Neurotrophic, anti-neuroinflammatory, and redox balance mechanisms of chalcones
Temitope Isaac Adelusi, Gbemisola Rebecca Akinbolaji, Xiaoxing Yin, et al.
European Journal of Pharmacology (2020) Vol. 891, pp. 173695-173695
Closed Access | Times Cited: 24
Neuroprotective effects of Petiveria alliacea on scopolamine-induced learning and memory impairment mouse model
Lizeth M. Zavala-Ocampo, Perla Y. López‐Camacho, Eva Aguirre-Hernández, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116881-116881
Closed Access | Times Cited: 8
Discovery and Optimization of a Series of Vinyl Sulfoximine-Based Analogues as Potent Nrf2 Activators for the Treatment of Multiple Sclerosis
Yoowon Kim, Jaehwan Kim, Byungeun Kim, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases
Zhenzhen Zhai, Yanxin Huang, Yawei Zhang, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1564-1564
Open Access | Times Cited: 10
H2S Alleviates Neuropathic Pain in Mice by Nrf2 Signaling Pathway Activation
Jun Wang, Nan Zhang, Hong-Zheng Liu, et al.
Journal of Molecular Neuroscience (2023) Vol. 73, Iss. 6, pp. 456-468
Closed Access | Times Cited: 5
Identification and evaluation of a napyradiomycin as a potent Nrf2 activator: Anti-oxidative and anti-inflammatory activities
Jin‐Sung Choi, Geum Jin Kim, Hyeon Jeong Kim, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104434-104434
Closed Access | Times Cited: 13
Discovery of 7-O-1, 2, 3-triazole hesperetin derivatives as multi-target-directed ligands against Alzheimer's disease
Min Wang, Longji Fang, Tongtong Liu, et al.
Chemico-Biological Interactions (2021) Vol. 342, pp. 109489-109489
Closed Access | Times Cited: 12
Recent Developments on the Synthetic and Biological Applications of Chalcones-A Review
Vagish Channa Basappa, Sowmya Ramaiah, Sudeep Penubolu, et al.
Biointerface Research in Applied Chemistry (2021) Vol. 12, Iss. 1, pp. 180-195
Open Access | Times Cited: 11
Mitigation of oxidative stress with dihydroactinidiolide, a natural product against scopolamine-induced amnesia in Swiss albino mice
Mamali Das, Devasahayam Jaya Balan, Kasi Pandima Devi
NeuroToxicology (2021) Vol. 86, pp. 149-161
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top